Private Sector Driving Pharma R&D, Finds Study
Posted on: Wednesday, 2 July 2008, 09:01 CDT
A new study has revealed that the private sector accounted for the major share in the development of the pharmaceutical science and new scientific discoveries and innovations, according to the PharmaTimes.
According to the study, the private sector played a pivotal role in the discovery or development of virtually all the drugs studied. The study literature contained the summary case histories of 35 drugs and drug classes that were identified as the most prescribed in 2007.
Of the 35 drugs and classes studied, the study found that private-sector research was responsible for central advances in basic science for seven, in applied science for 34 and in the development of drugs yielding improved clinical performance or manufacturing processes for 28.
The study also highlighted the private-sector's role in the development of modern drugs for bacterial infections, hypertension and anemia drugs like Amgen's Epogen.
Source: Datamonitor
Related Articles
- OBS Medical Completes BioQT Cardiac Safety Analysis Supporting Prospective Drug Study
- Private Developer Sought for Lake Murray Lodge
- State Lakes May See Development: Senators Have Passed a Bill That Encourages Private Development on Federally Controlled Lakes.
- Many U.S. Post-Approval Drug Studies Unfinished
- LAWSUIT SETTLED; U.S. Pays $450,000 for Drug-Study Death
- Osta Biotechnologies Announces Promising Interim Results From Its Second Clinical Study on the Development of a Novel Blood Test for Osteoporosis
- Kinex Pharmaceuticals Selects Lead Drug Candidate for Clinical Development in Oncology
- Bias Seen in U.S. Drug Study Reporting
- AIDS Research Chief Altered Drug Study
- Flight of Privately Developed Craft Marks Beginning of New Era in Space
User Comments (0)
RSS Feeds